JP7035079B2 - 安定なプロテアーゼ変異型 - Google Patents
安定なプロテアーゼ変異型 Download PDFInfo
- Publication number
- JP7035079B2 JP7035079B2 JP2019555724A JP2019555724A JP7035079B2 JP 7035079 B2 JP7035079 B2 JP 7035079B2 JP 2019555724 A JP2019555724 A JP 2019555724A JP 2019555724 A JP2019555724 A JP 2019555724A JP 7035079 B2 JP7035079 B2 JP 7035079B2
- Authority
- JP
- Japan
- Prior art keywords
- protease variant
- seq
- kumamoricin
- amino acid
- variant according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108091005804 Peptidases Proteins 0.000 title claims description 81
- 239000004365 Protease Substances 0.000 title claims description 76
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims 19
- 102000004190 Enzymes Human genes 0.000 claims description 60
- 108090000790 Enzymes Proteins 0.000 claims description 60
- 238000006467 substitution reaction Methods 0.000 claims description 35
- 230000003213 activating effect Effects 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 11
- LLEUXCDZPQOJMY-AAEUAGOBSA-N Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(O)=O)=CNC2=C1 LLEUXCDZPQOJMY-AAEUAGOBSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 230000002047 thymogen Effects 0.000 claims description 8
- 108010014252 thymogen Proteins 0.000 claims description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 102000039446 nucleic acids Human genes 0.000 claims description 5
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 238000002703 mutagenesis Methods 0.000 claims description 4
- 231100000350 mutagenesis Toxicity 0.000 claims description 4
- 239000003674 animal food additive Substances 0.000 claims description 3
- 239000006052 feed supplement Substances 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 239000013598 vector Substances 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 2
- 108020004999 messenger RNA Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 241001442202 Alicyclobacillus sendaiensis Species 0.000 claims 1
- 238000013329 compounding Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 description 62
- 229940088598 enzyme Drugs 0.000 description 53
- 235000019419 proteases Nutrition 0.000 description 43
- 230000000694 effects Effects 0.000 description 39
- 238000000034 method Methods 0.000 description 28
- 230000035772 mutation Effects 0.000 description 27
- 150000001413 amino acids Chemical group 0.000 description 26
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 18
- 239000000523 sample Substances 0.000 description 15
- 239000000872 buffer Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 239000000758 substrate Substances 0.000 description 10
- 102000010911 Enzyme Precursors Human genes 0.000 description 9
- 108010062466 Enzyme Precursors Proteins 0.000 description 9
- 239000004471 Glycine Substances 0.000 description 9
- 230000002779 inactivation Effects 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 229920004890 Triton X-100 Polymers 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 102000057297 Pepsin A Human genes 0.000 description 7
- 108090000284 Pepsin A Proteins 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 229940111202 pepsin Drugs 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 230000002797 proteolythic effect Effects 0.000 description 7
- 239000003599 detergent Substances 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000000087 stabilizing effect Effects 0.000 description 5
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108090000787 Subtilisin Proteins 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000010985 leather Substances 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 230000001338 necrotic effect Effects 0.000 description 4
- 239000003531 protein hydrolysate Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000005593 Endopeptidases Human genes 0.000 description 3
- 108010059378 Endopeptidases Proteins 0.000 description 3
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 3
- 239000006057 Non-nutritive feed additive Substances 0.000 description 3
- 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 101150025220 sacB gene Proteins 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 238000005496 tempering Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 239000002753 trypsin inhibitor Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 125000000899 L-alpha-glutamyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 2
- 241000579835 Merops Species 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 239000003541 chymotrypsin inhibitor Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000012411 cloning technique Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229940066758 endopeptidases Drugs 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000003471 mutagenic agent Substances 0.000 description 2
- 231100000707 mutagenic chemical Toxicity 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- 108010091212 pepstatin Proteins 0.000 description 2
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000004458 antinutrient Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000001202 beta-cyclodextrine Substances 0.000 description 1
- 108010050063 beta-naphthylsulfonyl-R-(d-Pip)-Ada-Abu-DYEPIPEEA-(Cha)-(d-Glu)-OH-AcOH Proteins 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000004293 potassium hydrogen sulphite Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003614 protease activity assay Methods 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- -1 two Chemical compound 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022031591A JP7344329B2 (ja) | 2016-12-22 | 2022-03-02 | 安定なプロテアーゼ変異型 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16206367 | 2016-12-22 | ||
| EP16206367.1 | 2016-12-22 | ||
| PCT/EP2017/084452 WO2018115473A2 (en) | 2016-12-22 | 2017-12-22 | Stable protease variants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022031591A Division JP7344329B2 (ja) | 2016-12-22 | 2022-03-02 | 安定なプロテアーゼ変異型 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505944A JP2020505944A (ja) | 2020-02-27 |
| JP2020505944A5 JP2020505944A5 (enExample) | 2021-02-04 |
| JP7035079B2 true JP7035079B2 (ja) | 2022-03-14 |
Family
ID=57629395
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555724A Active JP7035079B2 (ja) | 2016-12-22 | 2017-12-22 | 安定なプロテアーゼ変異型 |
| JP2022031591A Active JP7344329B2 (ja) | 2016-12-22 | 2022-03-02 | 安定なプロテアーゼ変異型 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022031591A Active JP7344329B2 (ja) | 2016-12-22 | 2022-03-02 | 安定なプロテアーゼ変異型 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11396648B2 (enExample) |
| EP (1) | EP3559225A2 (enExample) |
| JP (2) | JP7035079B2 (enExample) |
| KR (2) | KR102686572B1 (enExample) |
| CN (1) | CN110325636A (enExample) |
| AU (2) | AU2017380106B2 (enExample) |
| BR (1) | BR112019012980A2 (enExample) |
| CA (1) | CA3047868A1 (enExample) |
| MX (2) | MX2019007287A (enExample) |
| WO (1) | WO2018115473A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021368118A1 (en) * | 2020-10-30 | 2023-05-11 | The Regents Of The University Of California | Compositions and methods for treating celiac sprue disease |
| WO2023147350A1 (en) | 2022-01-26 | 2023-08-03 | Digestiva, Inc. | Blood glucose stabilizing methods and compositions |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013023151A2 (en) | 2011-08-10 | 2013-02-14 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| WO2015023728A1 (en) | 2013-08-14 | 2015-02-19 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| WO2016200880A1 (en) | 2015-06-08 | 2016-12-15 | University Of Washington | Compositions and methods for treating celiac sprue disease |
| WO2017220776A1 (en) | 2016-06-23 | 2017-12-28 | Ew Nutrition Gmbh | Feed composition comprising an acid protease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1600141B1 (en) * | 2004-05-24 | 2013-04-17 | 3M Deutschland GmbH | Collagenolytic active enzyme containing compositions for the treatment of dental caries |
-
2017
- 2017-12-22 AU AU2017380106A patent/AU2017380106B2/en active Active
- 2017-12-22 CA CA3047868A patent/CA3047868A1/en active Pending
- 2017-12-22 US US16/471,507 patent/US11396648B2/en active Active
- 2017-12-22 KR KR1020237022708A patent/KR102686572B1/ko active Active
- 2017-12-22 WO PCT/EP2017/084452 patent/WO2018115473A2/en not_active Ceased
- 2017-12-22 BR BR112019012980-4A patent/BR112019012980A2/pt unknown
- 2017-12-22 JP JP2019555724A patent/JP7035079B2/ja active Active
- 2017-12-22 MX MX2019007287A patent/MX2019007287A/es unknown
- 2017-12-22 CN CN201780087051.4A patent/CN110325636A/zh active Pending
- 2017-12-22 KR KR1020197020123A patent/KR102553627B1/ko active Active
- 2017-12-22 EP EP17835479.1A patent/EP3559225A2/en active Pending
-
2019
- 2019-06-19 MX MX2024000078A patent/MX2024000078A/es unknown
-
2022
- 2022-03-02 JP JP2022031591A patent/JP7344329B2/ja active Active
-
2024
- 2024-04-17 AU AU2024202526A patent/AU2024202526A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013023151A2 (en) | 2011-08-10 | 2013-02-14 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| WO2015023728A1 (en) | 2013-08-14 | 2015-02-19 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| WO2016200880A1 (en) | 2015-06-08 | 2016-12-15 | University Of Washington | Compositions and methods for treating celiac sprue disease |
| WO2017220776A1 (en) | 2016-06-23 | 2017-12-28 | Ew Nutrition Gmbh | Feed composition comprising an acid protease |
Non-Patent Citations (3)
| Title |
|---|
| Kumamoliisin-As，Database UniProtKB/Swiss-Prot [online]，2006年11月28日，Accession No. Q8GB88 |
| Peptidase S53 propeptide，Database Uniprot [online]，Accession No. J9HC20, entry version 19，2016年09月07日 |
| TSURUOKA N. et al.，Appl. Environ. Microbiol.，2003年，Vol.69 No.1，p.162-169 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102553627B1 (ko) | 2023-07-07 |
| EP3559225A2 (en) | 2019-10-30 |
| JP2020505944A (ja) | 2020-02-27 |
| KR102686572B1 (ko) | 2024-07-19 |
| KR20230107898A (ko) | 2023-07-18 |
| BR112019012980A2 (pt) | 2020-05-26 |
| US11396648B2 (en) | 2022-07-26 |
| WO2018115473A3 (en) | 2019-01-31 |
| CA3047868A1 (en) | 2018-06-28 |
| JP7344329B2 (ja) | 2023-09-13 |
| JP2022081554A (ja) | 2022-05-31 |
| WO2018115473A2 (en) | 2018-06-28 |
| MX2019007287A (es) | 2019-09-27 |
| CN110325636A (zh) | 2019-10-11 |
| US20190322994A1 (en) | 2019-10-24 |
| AU2024202526A1 (en) | 2024-05-30 |
| AU2017380106B2 (en) | 2024-05-09 |
| MX2024000078A (es) | 2024-02-23 |
| KR20190095361A (ko) | 2019-08-14 |
| AU2017380106A1 (en) | 2019-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Klomklao et al. | Trypsins from yellowfin tuna (Thunnus albacores) spleen: purification and characterization | |
| Fluhr et al. | Serpin protease inhibitors in plant biology | |
| Lufrano et al. | Molecular cloning and characterization of procirsin, an active aspartic protease precursor from Cirsium vulgare (Asteraceae) | |
| Ren et al. | Improving the catalytic performance of Proteinase K from Parengyodontium album for use in feather degradation | |
| JP7344329B2 (ja) | 安定なプロテアーゼ変異型 | |
| CN107208077A (zh) | 裂解镰孢毒素的多肽变体、包含所述多肽变体的添加剂和所述添加剂的用途，以及用于裂解镰孢毒素的方法 | |
| Gao et al. | Enhanced thermal stability and hydrolytic ability of Bacillus subtilis aminopeptidase by removing the thermal sensitive domain in the non-catalytic region | |
| Chang et al. | High level expression and biochemical characterization of an alkaline serine protease from Geobacillus stearothermophilus to prepare antihypertensive whey protein hydrolysate | |
| Tian et al. | Enhanced extracellular recombinant keratinase activity in Bacillus subtilis SCK6 through signal peptide optimization and site-directed mutagenesis | |
| Yamada et al. | A cysteine protease from maize isolated in a complex with cystatin | |
| Teo et al. | Cloning and characterization of a metalloprotease from Vibrio harveyi strain AP6 | |
| Mandujano-González et al. | Biochemical study of the extracellular aspartyl protease Eap1 from the phytopathogen fungus Sporisorium reilianum | |
| Park et al. | Chlorophyte aspartyl aminopeptidases: ancient origins, expanded families, new locations, and secondary functions | |
| Zou et al. | ADAM33 enzyme properties and substrate specificity | |
| Hang et al. | Structural insight into a novel neutral metalloproteinase from Paenibacillus spp. BD3526: Implications for mechanisms of rapid inactivation and calcium-dependent stability | |
| EP0970225B1 (en) | Improved metallo-endopeptidases | |
| Klomklao et al. | Cationic trypsin: A predominant proteinase in Pacific saury (Cololabis saira) pyloric ceca | |
| Balti et al. | Cathepsin D from the hepatopancreas of the cuttlefish (Sepia officinalis): purification and characterization | |
| US20230092791A1 (en) | Stable protease variants | |
| Oda et al. | Overview of the Properties of Glutamic Peptidases That Are Present in Plant and Bacterial Pathogens and Play a Role in Celiac Disease and Cancer | |
| Song et al. | Functional expression and characterization of a novel aminopeptidase B from Aspergillus niger in Pichia pastoris | |
| Klomklao et al. | Trypsin from the Pyloric Ceca of Pectoral Rattail (Coryphaenoides pectoralis): purification and characterization | |
| Li et al. | Site-directed mutagenesis of myofibril-bound serine proteinase from Crucian carp: possible role of Pro95, A127 and I130 on thermal stability | |
| Yamamoto et al. | Molecular characterization of a prolyl endopeptidase from a feather-degrading thermophile Meiothermus ruber H328 | |
| US7355004B2 (en) | Protein lipase inhibitor for flour and dough |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201221 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201221 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20211004 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220126 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220201 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220302 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7035079 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |